Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Director | June 10, 2026 | June 12, 2026 |
| RxSight, Inc.RXST · Entity 1226 | Director | June 17, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,038 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 14,965 · Balance 69,038 F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2: Includes 48,347 previously reported deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
F2: Includes 48,347 previously reported deferred stock units.
RxSight, Inc.
Report date June 17, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,172 |
Reported balance
After 2026-06-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 37,037 · Balance 55,172 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
F2: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 10, 2023
Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 23,993 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 9,988 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 9,988 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 18, 2026 20:09 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 37,037 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-275848 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,172 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:25 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269862 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,038 F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2 · balance_after: Includes 48,347 previously reported deferred stock units. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 20:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 18,841 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-088990 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,073 F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2 · balance_after: Includes 29,506 previously reported deferred stock units. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 01:35 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 10,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-081958 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,135 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 3, 2025. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 22, 2025 Filed Jan 27, 2025 21:40 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,519 | $30.87 | $108,618.16 |
DisclosureSEC source: 0000950170-25-009239 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,383 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on August 22, 2024 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 3,519 shares sold in the price range of $30.5166 to $31.26 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 00:26 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,782 | $45.88 | $173,518.16 |
DisclosureSEC source: 0000950170-24-131201 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,902 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on August 22, 2024 by the Reporting Person. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 11:05 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 15,152 | $12.87 | $195,006.24 |
DisclosureSEC source: 0000950170-24-075302 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,232 F1 · shares: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. F2 · balance_after: Includes 29,506 deferred stock units. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:20 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 2,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-071317 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,684 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 6, 2024. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 21:01 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,879 | $45.76 | $131,743.90 |
DisclosureSEC source: 0000950170-24-005766 · ownership.xml · nonDerivative · entry 2 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,130 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on May 25, 2023 by the Reporting Person. F3 · price: Represents the weighted average share price of an aggregate total of 2,879 shares sold in the price range of $45.33 to $46.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 21:01 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,520 | $45.69 | $160,811.55 |
DisclosureSEC source: 0000950170-24-005766 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,009 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on May 25, 2023 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 3,520 shares sold in the price range of $45.315 to $46.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 21:09 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 6,418 | $45.00 | $288,810.00 |
DisclosureSEC source: 0000950170-24-003334 · ownership.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,529 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on May 25, 2023 by the Reporting Person. Read SEC document |
| August 29, 2023 Filed Aug 29, 2023 21:10 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 4,292 | $28.06 | $120,450.69 |
DisclosureSEC source: 0001209191-23-047633 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,947 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on May 25, 2023 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 4,292 shares sold in the price range of $28.03 to $28.225 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:33 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 5,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034328 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,239 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 1, 2023. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| March 10, 2023 Filed Apr 5, 2023 22:35 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 4,262 | $17.75 | $75,650.50 |
DisclosureSEC source: 0001209191-23-023450 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,080 F1 · balance_after: Includes 14,354 previoiusly reported deferred stock units. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:04 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002657 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,040 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023. F2 · balance_after: Includes 14,052 deferred stock units. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:20 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerCommon Stock | 23,993 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-23-000044 · wf-form4_167331001726645.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 9,988 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. Read SEC document |
| January 05, 2023 Filed Feb 9, 2023 22:51 UTC Amendment | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008124 · doc4a.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,342 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders. F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023. F3 · balance_after: Includes 14,354 deferred stock units. Read SEC document |
| December 29, 2022 Filed Dec 30, 2022 21:29 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | SaleCommon Stock | 3,786 | $8.00 | $30,288.00 |
DisclosureSEC source: 0001637761-22-000134 · wf-form4_167243573955628.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,993 F1 · price: The transaction reported was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| June 02, 2022 Filed Jun 4, 2022 00:22 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034394 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,508 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 2, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:25 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 15,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000097 · wf-form4_165429148268412.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,779 F1 · shares: The restricted stock award vests in full on June 1, 2023, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:26 UTC | RxSight, Inc. RXST · Entity 1226 | GrantCommon Stock | 19,196 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000893 · doc4.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,196 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. F2 · shares: Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of January 3, 2022. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 6,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000131 · wf-form4_162283785377649.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,836 F1 · shares: The restricted stock award vests in full on June 2, 2022, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| April 01, 2021 Filed Apr 1, 2021 23:30 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 5,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000074 · wf-form4_161731974137075.xml · nonDerivative · entry 1 Maniar Shweta · CIK 0001850826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,583 F1 · shares: The restricted stock award vests in full on April 1, 2022, subject to the Reporting Person not experiencing a termination of service prior to such date and subject to accelerated vesting in the event of the Reporting Person's death or disability. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.